Aspen Pharmacare in talks for Merck API facility in the Netherlands

10:08 AM MST | February 4, 2013 | Francinia Protti-Alvarez

Aspen PharmaCare (Durban, South Africa) is in discussions with Merck Sharp Dohme (MSD; Darmstadt, Germany) regarding a possible acquisition of a Merck active pharmaceutical ingredient (API) facility in the Netherlands and a related portfolio of pharmaceutical finished dose form products, Aspen announced today. No further details were immediately...